Baillie Gifford & Co. Has $33.81 Million Position in Trupanion, Inc. (NASDAQ:TRUP)

Baillie Gifford & Co. boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 26.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 701,366 shares of the financial services provider's stock after purchasing an additional 147,341 shares during the quarter. Baillie Gifford & Co. owned about 1.66% of Trupanion worth $33,806,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC boosted its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock worth $49,213,000 after purchasing an additional 1,170,202 shares during the period. Barclays PLC boosted its position in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after purchasing an additional 47,262 shares during the period. Centiva Capital LP bought a new stake in shares of Trupanion in the third quarter valued at about $595,000. FORA Capital LLC bought a new stake in shares of Trupanion in the third quarter valued at about $540,000. Finally, Blueshift Asset Management LLC boosted its position in shares of Trupanion by 215.8% in the third quarter. Blueshift Asset Management LLC now owns 37,230 shares of the financial services provider's stock valued at $1,563,000 after acquiring an additional 25,440 shares during the period.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the business's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the completion of the transaction, the chief financial officer now owns 9,867 shares of the company's stock, valued at approximately $519,102.87. The trade was a 5.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Emily Dreyer sold 900 shares of the business's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now directly owns 23,808 shares of the company's stock, valued at approximately $1,298,726.40. The trade was a 3.64 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,581 shares of company stock valued at $615,159. 5.50% of the stock is currently owned by corporate insiders.

Trupanion Price Performance

TRUP stock traded down $2.45 during midday trading on Friday, reaching $32.95. The company had a trading volume of 1,785,171 shares, compared to its average volume of 630,090. The company has a market capitalization of $1.40 billion, a price-to-earnings ratio of -143.26, a price-to-earnings-growth ratio of 8.29 and a beta of 1.60. The stock has a 50 day moving average price of $48.04 and a 200-day moving average price of $47.89. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%. Equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on TRUP shares. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday. Piper Sandler reduced their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a research report on Thursday, October 31st. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Trupanion has an average rating of "Moderate Buy" and an average price target of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.